The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes
about
Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ...Epicardial Fat: Physiological, Pathological, and Therapeutic ImplicationsLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewAntiartherosclerotic effects of plant flavonoidsAtheroprotective effects of statins in patients with unstable angina by regulating the blood-borne microRNA networkBenefits of statin therapy and compliance in high risk cardiovascular patients.Atorvastatin inhibits the expression of RAGE induced by advanced glycation end products on aortas in healthy Sprague-Dawley ratsMitophagy is required for acute cardioprotection by simvastatin.Effects of statins on the epicardial fat thickness in patients with coronary artery stenosis underwent percutaneous coronary intervention: comparison of atorvastatin with simvastatin/ezetimibeStatins use and coronary artery plaque composition: results from the International Multicenter CONFIRM Registry.The effect of rosuvastatin on thromboinflammation in the setting of acute coronary syndromeComparison of anti-inflammatory effect of atorvastatin with rosuvastatin in patients of acute coronary syndromeEffects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarctionHighly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromesLipid-lowering effects of statins: a comparative review.Intensive statin therapy for treating acute coronary syndromes.Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm.Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors.Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention.Amelioration of cisplatin-induced nephrotoxicity by statins.Impact of Statins Therapy for Ischemic Heart Disease Patients with Low-Density Lipoprotein Cholesterol Levels Less Than 100 mg/dL.An emerging paradigm in atherosclerosis: focus on subclinical disease.Impact of the CD40-CD40L dyad in Alzheimer's disease2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiTargeting tumor cell metabolism with statins.Statins and pregnancy: between supposed risks and theoretical benefits.Pravastatin and fenofibrate in combination (Pravafenix(®)) for the treatment of high-risk patients with mixed hyperlipidemia.Association between preoperative statin therapy and postoperative infectious complications in patients undergoing cardiac surgery: a systematic review and meta-analysis.A review of statin use in patients with acute coronary syndrome in Western and Japanese populations.Statins and Cataracts--a visual insight.Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials.A focus on inflammation as a major risk factor for atherosclerotic cardiovascular diseases.Inflammatory cytokines in atherosclerosis: current therapeutic approaches.Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.Anti-Thrombotic Effects of Statins in Acute Coronary Syndromes: At the Intersection of Thrombosis, Inflammation, and Platelet-Leukocyte Interactions.Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo.Protective Effects of Simvastatin, a Lipid Lowering Agent, against Oxidative Damage in Experimental Diabetic Rats.Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pAtorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products.Statins Do Not Reduce Atrial Fibrillation After Cardiac Valvular Surgery: A Single Centre Observational Study.
P2860
Q24650933-46EB2DA6-3927-49ED-8BFE-FB96FCE826E4Q26746996-0A7BA23D-FC2F-4036-87B7-16C039B03027Q28755180-9CDFF135-0D54-4D02-9B03-1B9A8C32F038Q33757899-9881EE58-E186-4386-9A36-82C2B514BDFDQ33828323-E83D1A0C-1D4A-4993-9660-5A85DB6CE11FQ34187551-7C89E4F0-6F7B-4677-9593-EA6149AF1529Q34269548-5A6996BF-AD25-4CF3-93D8-D5D42F045898Q34399751-30FF28F8-9C27-447B-A2E5-7BF5D731E910Q34495566-BC9F9EED-6DFE-4D48-B56F-879F484B2C47Q34778785-60164914-FB35-4522-A9F6-FAD759B125FEQ35059481-1FBC40DA-1E42-4C26-A35A-BA233A3BF453Q35979800-541D49B7-8577-4DC1-B731-89AB34F6CFE5Q36071485-F22F74D3-938D-4F3A-A546-FDCD83DC33DFQ36095925-85EF622A-8312-4659-B7C4-9069D577D182Q36573878-43ECBE0B-5BFE-49CE-BC1B-DB1BB840A7A9Q36600272-1CE068E8-9DA6-42C5-98B3-08667D84DCB7Q36956805-C03802D6-5DDA-44C5-A6F7-2534A7236BB7Q36985325-B18C4A8C-9F9E-4AA1-B80D-90F151D5E888Q37016141-AFA64854-3901-4273-8996-4B4C1A282686Q37133302-793E0DCB-BC9E-4A07-A78F-C1F2B080CDFAQ37314512-A2B471BD-0E1E-49C4-9792-388D4C97E0F7Q37427239-000717F7-E6AD-4D93-9A90-9C2A1BF37F9CQ37703298-7C6131A7-E2C5-46C0-9B94-518BA937AD6DQ37953885-03CD8572-2235-4F01-B80E-13B977D5E650Q37981833-613E5550-459C-4A30-A03C-7983E854E414Q38000338-6073DD63-2EE2-47F5-AE2D-A5939FD057CEQ38014975-8F19FD43-7E05-4115-A956-C75DDBB1E3F7Q38049984-9A444DF1-CE20-47E2-8122-7EC63A7703E6Q38097397-4F52768D-6919-450E-9461-8ACD84C88403Q38285483-5FA9D521-4484-423A-98E5-6320C1C800A2Q38367085-929976AE-45C5-428B-9C01-C074B53522BBQ38660995-084B340E-1954-40E0-8ECC-AC893A094EF7Q38722298-B38380C1-03DA-46EF-9C14-8AE8FE43F2CDQ38786058-B671B6C5-6006-4BE0-A2B7-873757B54F55Q38824464-3E23F724-34BC-4F10-8DA4-C361E933EE42Q39107997-E15D0067-7F17-48CA-BE9B-157AAE249224Q39752326-D7932501-A97C-43A4-8E93-1CBFA82F59B4Q41082977-6E2C2094-7354-4AC1-B8D5-F39026316DDFQ41894332-CA3F2619-028F-4F37-813D-78FE14EC2BB4Q42067173-E2DF3C9A-5DE7-4A49-AEE2-A6C9055676EA
P2860
The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@ast
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en-gb
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@nl
type
label
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@ast
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en-gb
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@nl
altLabel
The potential relevance of the ...... nt of acute coronary syndromes
@en
prefLabel
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@ast
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en-gb
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@nl
P3181
P1476
The Potential Relevance of the ...... nt of Acute Coronary Syndromes
@en
P2093
Christopher P. Cannon
Kausik K. Ray
P304
P3181
P356
10.1016/J.JACC.2005.05.086
P407
P577
2005-10-01T00:00:00Z